CSD: A Hold As Soft Risk-Adjusted Returns Overshadow Recent Outperformance

Invesco S&P Spin-Off ETF offers exposure to a concentrated portfolio of U.S. companies that have been spun off from larger players "within the past four years."

Seeking Alpha • Feb 23, 2026

CSD: U.S. Spin-Off ETF Not Meeting Expectations

CSD is comprised of U.S. companies that have spun-off from their parent companies over the last four years. Its ER is 0.64% and the ETF has $63 million in AUM. Long-term research provided by S&P Global Market Intelligence suggests investing in spin-offs can substantially outperform the broader market. However, that hasn't translated into solid real-world results. CSD has struggled since its Index change in May 2016, delivering about half the total return of the S&P 500.

Seeking Alpha • May 9, 2025

Tech IPOs Poised For Return To Pre-Pandemic Normalcy In 2025

The new year is poised for a resurgence in tech IPOs, as lower interest rates and an investor shift to small- and mid-cap companies combine to create a more welcoming market for debuts. The current environment presents the most favorable conditions for the recovery of IPOs in the past three years. The S&P 400 Midcap Index and the S&P 600 Index have outperformed the S&P 500 Index since the US election Nov. 5.

Seeking Alpha • Dec 11, 2024

Tap Into Trends: 3 Thematic ETFs to Capture the Market's Pulse

Today, we discuss three thematic ETFs to buy for investors looking to tap into future trends, consumer preferences or disruptive technologies. Metrics suggest how fast investor sentiment towards certain themes, industries, countries or stocks may change on Wall Street.

InvestorPlace • May 13, 2024

Why Now For U.S. Equity Income?

US equities, as measured by the S&P 500 Index, have performed strongly so far in 2023.

Seeking Alpha • Dec 11, 2023

ETFs to Bet on the Successful Debut of Kenvue

Kenvue is the world's largest pure-play consumer health company by revenue, and makes well-known products, including Tylenol, Neutrogena, Listerine, Johnson???s', Band-Aid, Aveeno, Zyrtec and Nicorette.

Zacks Investment Research • May 5, 2023

Get Exposure to GE HealthCare With RYH and CSD

Shares of GE HealthCare Technologies Inc. are up more than 3.5% in mid-day trading Monday after the company delivered strong revenue growth in its first results as a public company. The Chicago-based global medical technology company on Monday reported revenue growth of 7.6% to 4.

ETF Trends • Jan 30, 2023

Spinoff ETF Could Spin Back Into Spotlight

More companies are turning to spinoffs as a way of unlocking shareholder value, and that could have implications for the Invesco S&P Spin-Off ETF (NYSEARCA:CSD) — the lone exchange traded fund dedicated to this particular corporate action. Last year, 34 companies announced spinoffs, and there are 20 such deals waiting to be completed across a variety [.

ETF Trends • Mar 29, 2022

7 Innovative Stocks With Their Eyes on the Future

We believe these innovative stocks are forward-thinking and disruptive and therefore belong in long-term portfolios. The post 7 Innovative Stocks With Their Eyes on the Future appeared first on InvestorPlace.

InvestorPlace • Sep 30, 2020

How Corporate Action ETFs Work

Corporate actions like IPOs, M&A and spinoffs are picking up pace. These ETFs may benefit.

ETFcom • Sep 22, 2020